BIOGAMI funds innovative research to understand and manipulate the biomolecular grammar of intrinsically disordered proteins to prevent neurodegenerative diseases. It supports projects that develop interventions to reverse protein misfolding and technologies to detect early aggregation signs, leveraging machine learning and AI to halt disease progression at its earliest stages.
Eligibility criteria are not specified for this funding opportunity.
